SAI LIFE SCIENCES LIMITED Share Price - Live NSE: SAILIFE Stock Price & Chart
NiveshIQ
NSE: SAILIFE · Healthcare
Sai Life Sciences Ltd.
₹1,585.00▼ ₹6.10 (-0.38%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on SAILIFE. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Sai Life Sciences Ltd.
Sai Life Sciences Limited is a contract research, development, and manufacturing organization (CRDMO) that provides a range of services including medicinal chemistry, pharmacokinetics, manufacturing, and contract development to the global pharmaceutical industry. The company's core business is driven by its contract research and manufacturing capabilities, with key revenue drivers including strong growth in its CRO and CDMO segments. Recently, Sai Life Sciences reported a 12% year-over-year increase in Q1 FY27 revenue, driven by robust growth in its CRO and CDMO businesses, with revenue rising to ₹554 crore. The company's net profit also increased by 22% year-over-year to ₹73 crore in Q1 FY27, driven by higher margins and strong operational performance. Sai Life Sciences' competitive posit
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1,465 Cr +20.40% | ₹1,696 Cr +15.80% | ₹2,192 Cr +29.30% |
| EBITDA Margin | 26.85% | 23.94% | 31.03% |
| Net Profit | ₹83.00 Cr +730.00% | ₹170.00 Cr +104.80% | ₹348.91 Cr +105.20% |
| EPS | – | ₹6.83 | ₹16.63 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Sai Life Sciences (SAILIFE.NS) Slips Over 5% as Stock Retreats Toward Key Support - Long Short Pair
Sai Life Sciences Bets on New Capacity, Peptide Push for Second-half Growth
🔒
+ 3 more stories about Sai Life Sciences Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹554 Cr, PAT ₹73 Cr, EPS ₹3.46, EBITDA margin 27.3%. Growth context: revenue QoQ -7.9%, PAT QoQ -29.7%. Street verdict: inline, revenue surprise -2.8%, PAT surprise -4.1%.
Key growth drivers for SAILIFE in the near term are poised to be order wins, a robust deal pipeline, and a burgeoning ba...
In FY26, SAILIFE reported revenue of ₹2, 192 Cr, PAT of ₹349 Cr, an EBITDA margin of 31.0%, and EPS of ₹16.63, represent...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for SAILIFE
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track SAILIFE alongside your other holdings
Unlock full SAILIFE research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Sai Life Sciences Ltd.?
NiveshIQ detects active intelligence signals for Sai Life Sciences Ltd. (SAILIFE) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Sai Life Sciences Ltd.?
Sai Life Sciences Ltd. operates in the Healthcare sector with a market capitalisation of ₹2,700,490.3L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.